Change over period: —
NSE · ASTEC
ASTEC LIFE
-40.3% from the 52-week high · +5.1% above the low
Astec LifeSciences Ltd. engages in the manufacture and sale of agrochemicals and pharmaceutical intermediates. The company is headquartered in Mumbai, Maharashtra and currently employs 551 full-time employees. The company went IPO on 2009-11-25. The firm operates through the Agrochemicals segment. The company manufactures a range of fungicides, insecticides, herbicides, and intermediates for its global customers. The Company’s products and intermediates includes triazole fungicides, heterocyclic herbicides, sulfonylurea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, silane derivatives, fluorinated aromatic, aliphatic and heterocyclic intermediates, fluorinated aromatic amines, fluorinated pyridine derivatives, fluorinated aromatic carboxylic acids, fluorinated benzyl alcohols, fluorinated ketones and benzophenones, fluorinated heterocyclic mercaptans, heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans, thorium salts, pyrazalone’s and heterocyclic sulfonyl chlorides.
The short version. ASTEC LIFE reported revenue of ₹72 crore for Sep 2026, down 2.7% from a year earlier. Net profit was ₹-37 crore. Return on equity was -20.7% in Mar 2026. Promoter holding was 71.96% in Sep 2026, up 5.21 points over 8 quarters.
1 · The price
How has the stock traded?
ASTEC LIFE trades 40.3% below its 52-week high and 5.1% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹72 cr.
18.8 pts lower than a year earlier.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 72 | 84 | 159 | 125 | 74 | 91 | 120 | 94 |
| Net profit | -37 | -19 | -8 | -16 | -24 | -33 | -16 | -40 |
| Net margin % | -51.9 | -22.4 | -4.9 | -12.6 | -33.1 | -36.3 | -13.5 | -43.0 |
| EPS (₹) | -16.79 | -8.4 | -3.48 | -7.04 | -10.96 | -14.74 | -7.18 | -18.02 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 448 | 381 | 458 | 628 | 677 | 555 | 523 | 431 |
| Net profit | -81 | -135 | -47 | 26 | 90 | 65 | 48 | 36 |
| Net margin % | -18.1 | -35.3 | -10.2 | 4.1 | 13.3 | 11.7 | 9.1 | 8.3 |
| EPS (₹) | -36.31 | -60.12 | -20.94 | 11.41 | 40.12 | 29.07 | 21.24 | 15.99 |
3 · The quality
How well does it turn capital into profit?
Return on equity was -20.7% in Mar 2026; debt to equity is 1.15.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | -20.7 | -57.4 | -12.7 | 6.1 |
| Return on capital % | -10.5 | -20.2 | -6.3 | 12.3 |
| EBITDA margin % | -0.3 | -15.7 | -0.1 | 13.9 |
| Net margin % | -17.8 | -34.8 | -10.1 | 4.0 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | -10.9% | -4.2% |
| Profit CAGR | — | — |
4 · The owners
Who holds it, and are they adding?
Up 5.21 pts over 8 quarters.
Down 1.17 pts over 8 quarters.
Down 2.07 pts over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 66.75 | 70.87 | 70.87 | 72.42 | 71.97 | 71.97 | 71.96 | 71.96 | +5.21 |
| FII | 1.2 | 0.25 | 0.02 | 0 | 0.04 | 0.02 | 0.01 | 0.03 | -1.17 |
| DII | 5.41 | 4.34 | 4.26 | 4.01 | 3.17 | 3.34 | 3.33 | 3.34 | -2.07 |
| Public | 26.64 | 24.54 | 24.84 | 23.57 | 24.82 | 24.67 | 24.69 | 24.67 | -1.97 |
Mutual fund holdings · Oct 2026
3 schemes hold this stock
3 the month before.
- ICICI Prudential Commodities Fund0.18% of NAV
- NIPPON INDIA SMALL CAP FUND0.04% of NAV
- ICICI Prudential Mid Cap Fund0.01% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for ASTEC LIFE are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Fertilizers & Agrochemicals stocks
Quick answers
Common questions about ASTEC LIFE
What is the ASTEC LIFE share price?
ASTEC LIFE (ASTEC) last closed at ₹546.05, down 0.42% on the day. Its 52-week range is ₹521.85 to ₹918.75.
What is the market cap of ASTEC LIFE?
ASTEC LIFE has a market capitalisation of about ₹1,223 crore.
How are ASTEC LIFE's latest results?
ASTEC LIFE reported revenue of ₹72 crore for Sep 2026, down 2.7% from a year earlier. Net profit was ₹-37 crore. Return on equity was -20.7% in Mar 2026. Promoter holding was 71.96% in Sep 2026, up 5.21 points over 8 quarters.
Who owns ASTEC LIFE?
As of Sep 2026, shareholding was: Promoter 71.96%, FII 0.03%, DII 3.34%, Public 24.67%.
How many mutual funds hold ASTEC LIFE?
3 mutual fund schemes held ASTEC LIFE in October 2026. That compares with 3 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 04 Jul 2025 · Rights issue 1:7
- 21 Jul 2023 · Final Dividend - Rs. 1.5
- 19 Jul 2022 · Final Dividend - Rs. 1.5
- 22 Jul 2021 · Final Dividend - Rs. 1.5
- 16 Jul 2020 · Final Dividend - Rs. 1.5
- 18 Jul 2019 · Final Dividend - Rs. 1.5
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.